Academic Journals Database
Disseminating quality controlled scientific knowledge

Onconase: A ribonuclease with antitumor activity

ADD TO MY LIST
 
Author(s): Małgorzata Zwolińska | Piotr Smolewski

Journal: Postępy Higieny i Medycyny Doświadczalnej
ISSN 0032-5449

Volume: 64;
Issue: 840537;
Start page: 58;
Date: 2010;
Original page

Keywords: onkonaza | rybonukleaza | apoptoza | aktywność przeciwnowotworowa

ABSTRACT
Onconase (ranpirnase) is a homologous protein obtained from [i]Rana pipiens [/i]frog eggs. The activity of onconase, and particularly its antitumor effect, is strictly connected with ribonuclease (RN-ase) activity. Onconase induces cell death through the decomposition of inner cellular RNA, inhibition of protein synthesis, and inhibition of cell growth and proliferation and it also specifically triggers tumor cell apoptosis. A very important mechanisms of its cytotoxicity is also its antioxidant activity. The results of preclinical trials demonstrated a high activity of onconase against tumor cells, also those resistant to cytostatics. Moreover, onconase showed synergic activity with other commonly used anticancer drugs. Several clinical trials were performed on patients suffering from kidney, breast, and pancreatic cancers. Most recently a phase III study of onconase in patients with mesothelioma was completed. There are also ongoing phase I and II clinical trials with non-small-cell lung cancer (NSCLC).
Why do you need a reservation system?      Affiliate Program